FUJIREBIO Overview
Company Headquarters: Tokyo, Japan
Founded: 1950
Workforce: ~ 500
Company Working:
Fujirebio is a global leader in high-quality in-vitro diagnostic (IVD) products. It has 50 years of experience in the conception, development, production, and worldwide commercialization of robust IVD products. It operates through regions such as the US, Latin America, Europe, and Asia. It serves over 80 leading healthcare organizations worldwide. It is one of the worldwide suppliers of high-quality, innovative in-vitro diagnostic (IVD) products. Fujirebio is a part of Miraca Group, a global Japanese healthcare player. It is one of the world leaders in strip-based diagnostic solutions.
Strategy
Fujirebio aims to provide high-quality, innovative services pertaining to healthcare management worldwide. The company strategizes to diversify its product portfolio through strategic acquisitions. Its focus is to improve the quality of life of patients by providing them with better healthcare facilities and better treatment options. The strategy of Fujirebio is to bring solid and successful automated immunoassay testing solutions and state of the art chemiluminescent assay products to the market.
